Loading...
Please wait, while we are loading the content...
Similar Documents
Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome associated with clopidogrel: report of two new cases.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Andersohn, Frank Hagmann, F. G. Garbe, Edeltraut |
| Copyright Year | 2004 |
| Abstract | Clopidogrel has been reported to be safe and effective in reducing vascular events. Nevertheless, there is growing evidence that clopidogrel may cause thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome (TTP/HUS). This association has been debated, since in several cases alternative causes could not be excluded. Two new cases of TTP/HUS associated with clopidogrel are reported here. After discontinuation of clopidogrel and treatment with plasma exchange, both patients had a complete and sustained recovery from TTP/HUS. These cases corroborate previous observations that clopidogrel may indeed be a rare cause of TTP/HUS. |
| Starting Page | e57 |
| Ending Page | e57 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://heart.bmj.com/content/heartjnl/90/9/e57.full.pdf |
| PubMed reference number | 15310726v1 |
| Volume Number | 90 |
| Issue Number | 9 |
| Journal | Heart |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Exclusion Hemolytic-Uremic Syndrome Patients Plasmapheresis Purpura, Thrombotic Thrombocytopenic Thrombocytopenic purpura Thrombotic Microangiopathies clopidogrel |
| Content Type | Text |
| Resource Type | Report |
